Business Wire

U.S. FDA Grants Artera Breakthrough Device Designation for AI-Powered Software Transforming ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug ...